Tag Archives: Vanessa’s Law
Matthew Herder shares a template letter that physicians, researchers, civil society groups, investigative journalists, and others can use to gain access to unpublished pharmaceutical safety and effectiveness data.
Matthew Herder and Trudo Lemmens explore the ways that Canada’s transparency legislation may limit researchers’ abilities to scrutinize drug safety and effectiveness.
Matthew Herder says it is unclear whether the ‘Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law)’ will provide greater transparency in Canadian drug regulation.
Matthew Herder explains why Health Canada’s “life cycle” approach to drug regulation may be beyond the regulator’s mandate.